<DOC>
	<DOCNO>NCT01631890</DOCNO>
	<brief_summary>Consecutive patient meet eligibility criterion enrol study . All patient gastric varix history gastric variceal bleed ( Group C ) undergo Endoscopic ultrasound Upper Gastrointestinal Endoscopy baseline , end first year end study . The patient present Institute Liver Biliary Sciences gastric variceal bleed develop Gastric Variceal bleed hospital stay randomize Group -A ( conventional Upper Gastrointestinal Endoscopy + Glue ) Group-B ( Endoscopic Ultrasound follow Upper Gastrointestinal Endoscopy+Glue ) therapy gastric varix . Total 90 patient enrol randomize group A Group B resuscitation urgent Upper Gastrointestinal Endoscopy standard therapy bleed gastric varix achieve hemostasis .</brief_summary>
	<brief_title>To Compare Efficacy Endoscopic Ultrasound Assisted Endoscopic Glue Injection Conventional Endoscopic Injection Therapy Prevention Gastric Variceal Rebleed</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<criteria>A clinical , radiological histologic diagnosis cirrhosis Upper Gastrointestinal endoscopy show gastric varix Informed consent participate study Previous endotherapy ( Endoscopic Variceal Ligation/Esophageal Variceal Sclerotherapy/Endoscopic Variceal Obliteration ) gastric variceal haemorrhage Diagnosed case HepatoPulmonary Syndrome . Non cirrhotic portal hypertension/Extra hepatic Portal Venous Obstruction transhepatic intrajugular portosystemic shunt , ( balloonoccluded retrograde transvenous obliteration ) , balloonoccluded endoscopic injection sclerotherapy , shunt operation . Hepatic encephalopathy grade III/IV , Cardio respiratory failure Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>